- Case report
- Open Access
Blurred vision due to choroidal metastasis as the first manifestation of lung cancer: A case report
© Asteriou et al; licensee BioMed Central Ltd. 2010
- Received: 28 October 2009
- Accepted: 8 January 2010
- Published: 8 January 2010
Reduction in visual acuity combined with blurred vision is rarely the first sign of lung cancer and very few cases have been announced globally.
A case of a 46-year-old man who admitted with blurred vision is presented. His medical history, apart from a mild gastritis under treatment was negative. Ocular examination revealed a decrease in visual acuity due to a choroidal tumor. Further image body scans demonstrated a right lung lesion with dissemination to other organs. Diagnosis of a non-small cell lung cancer established after a VATS biopsy carried out.
Blurred vision due to choroidal metastasis as the primary symptom of lung cancer is very uncommon. A great index of suspicion is essential when a choroidal lesion appears.
- Lung Cancer
- Central Nervous System Metastasis
- Choroidal Metastasis
- Transthoracic Needle Biopsy
- Secondary Metastasis
The incidence of ocular metastases from lung cancer is reported to be 2-7% according to the international literature [1, 2]. The majority of cases involves end-stage patients. Choroidal metastases are metastatic lesions to the choroid layer of the eye. Decrease in optical acuity as the initial manifestation of lung cancer is infrequent.
The highly vascular uveal tract is the most common part of the eye involved by metastases. Within the uvea, the choroid (88%) is the most commonly affected site followed by the iris (9%) and ciliary body (2%) . Breast cancer seems to be the most frequent type of cancer giving intraocular metastases. The incidence for the breast cancer is reported to be 37-41%, while lung cancer is considered to be responsible for no more than 7% of choroidal metastases [4, 5]. It is generally considered that these kind of metastatic lesions occur at the final stage of the disease, where the mean survival is not expected to be more than 6 months and the majority of the patients already suffer from the typical lung cancer symptoms . The reason for this unusual site to be target for secondary metastases from lung cancer is generally unknown. It is, however, speculated that its high vascularity may consist a reasonable explanation . The diagnosis of ocular metastases is based primarily on clinical findings supplemented by imaging studies. The diagnostic procedures include ultrasonography, fluorescein angiography, computed tomography/MRI, fine-needle aspiration, or wedge biopsy. Brain imaging is useful before initiation of radiotherapy to assist in treatment planning. It is reported that 22% of patients diagnosed with choroidal metastasis had a concurrent diagnosis of central nervous system metastasis . Differential diagnosis includes primary choroidal melanomas, benign lesions such as haemangioma, and inflammatory granulomas.
Decrease in vision and blurredness as the initial manifestation of lung carcinoma is therefore very rare. A review of the literature brought to light 12 cases of lung cancer patients suffering from choroidal metastases as the primary clinical sign. In all cases, the diagnosis of the choroidal metastases declares final stage disease and the dissemination seems to be almost certain. Prognosis is poor and life expectancy short.
Treatment for ocular metastases is palliative because the presence of such metastases suggests hematogenous spread of cancer. In line with this, the aims for treatment are to maximize quality of life, and restore or preserve vision. This may be achieved with either radiotherapy or chemotherapy. Surgery has not played an important role other than diagnostic biopsy, as surgery carries great potential morbidity and often there is no need for tumor debulking.
In conclusion, when a choroidal lesion is discovered, the differential diagnosis should include secondary metastases due to malignant tumors originated from distal organs.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Kreusel KM, Bornfeld N, Hosten N, Wiegel T, Foerster MH: Solitary choroidal metastasis as the first sign of metastatic lung carcinoid. Arch Ophthalmol. 1998, 116: 1396-1.View ArticlePubMedGoogle Scholar
- Simsek T, Ozdamar Y, Berker N: Choroidal mass as an initial presentation of lung cancer. Med Oncol. 2008, 25: 400-2. 10.1007/s12032-008-9053-3.View ArticlePubMedGoogle Scholar
- George B, Wirostko WJ, Connor TB, Choong NW: Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. J Thorac Oncol. 2009, 4 (5): 661-2. 10.1097/JTO.0b013e31819c9a73.View ArticlePubMedGoogle Scholar
- Fernandes BF, Fernandes LH, Burnier MN: Choroidal mass as the presenting sign of small cell lung. Can J Ophthalmol. 2006, 41: 605-8.View ArticlePubMedGoogle Scholar
- Kreusel KM, Wiegel T, Stange M, Bornfeld N, Hinkelbein W, Foerster MH: Choroidal metastasis in disseminated lung cancer: frequency and risks factors. Am J Ophthalmol. 2002, 134: 445-7. 10.1016/S0002-9394(02)01580-5.View ArticlePubMedGoogle Scholar
- J Fernando A, Fernandez CF, Garcia RA: Optical Coherence Tomography. Characteristics of Choroidal Metastasis. Ophthalmol. 2005, 122: 1612-1619.Google Scholar
- Ascaso FJ, Castillo JM, García FJ, Cristóbal JA, Fuertes A, Artal A: Bilateral Choroidal Metastases Revealing an Advanced Non-Small Cell Lung Cancer. Ann Thorac Surg. 2009, 88: 1013-5. 10.1016/j.athoracsur.2009.02.019.View ArticlePubMedGoogle Scholar
- Koçak Z, Tabakoğlu E, Benian O, Bayir G, Unlü E, Uzal C: Bilateral choroidal metastases as an initial manifestation of small-cell carcinoma of the lung. Tuberk Toraks. 2006, 54 (1): 61-4.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.